RxDoctor Payments Data

Marie Stewart

Family · Franklin, TNNPI 1578117560

Payments from drug & device makers

$530in general payments, 2019–2025

Across 30 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$202
  • AbbVie$89
  • Jazz Pharmaceuticals Inc.$61
  • Novo Nordisk$45
  • Lilly USA, LLC$45
  • Harmony Biosciences LLC$26
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$25,184
Medicare patients
181
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$56,228
MounjaroTirzepatide33$53,027
EliquisApixaban43$49,351
FarxigaDapagliflozin Propanediol39$49,128
Tresiba Flextouch U-200Insulin Degludec17$30,544
XareltoRivaroxaban25$24,871
TradjentaLinagliptin16$23,250
TrulicityDulaglutide12$18,819
JardianceEmpagliflozin18$18,011
JanuviaSitagliptin Phosphate13$15,653
Tresiba Flextouch U-100Insulin Degludec25$10,200
Breo ElliptaFluticasone/Vilanterol17$9,860
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,830
Duloxetine Hcl74$3,408
Albuterol Sulfate HfaAlbuterol Sulfate142$2,731

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$45$71,84645 claims
Novo NordiskOzempic$45$56,22846 claims
PfizerEliquis$16$49,35143 claims
AstraZenecaFarxiga$12$49,12839 claims
AbbVieSynthroid$89$1,88822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →